Age(years) |
63.5±8.7 |
64.1±9.5 |
63.5±9.3 |
0.870*
|
Male gender, n (%) |
55 (66.3) |
63 (80.8) |
92 (72.4) |
0.116
#
|
Hypertension, n (%) |
56 (67.5) |
55 (70.5) |
95 (74.8) |
0.502
#
|
Previous CVA, n (%) |
5 (6) |
4 (5.1) |
9 (7.1) |
0.849
#
|
PAD, n (%) |
7 (8.4) |
8 (10.3) |
22 (17.3) |
0.123
#
|
Ejection fraction (%) |
50.1± 8.3 |
52.0± 9.3 |
49.9± 10.5 |
0.187
¶
|
LAD, (mm) |
38.4± 4.4 |
37.6± 3.7 |
38.1± 4.0 |
0.151¶
|
BMI (kg/m2) |
28.0±4.3 |
27.3±4.0 |
28.3±4.1 |
0.404
¶
|
Preoperative drugs |
|
|
|
|
Oral antidiabetics, n (%) |
39 (47) |
29 (37.2) |
36 (28.3) |
0.022 # |
Insulin, n (%) |
39 (47) |
46 (59) |
71 (55.9) |
0.272
#
|
No antidiabetic usage, n (%) |
5 (6) |
3 (3.8) |
20 (15.7) |
0.008 # |
Beta-blocker, n (%) |
78 (94.0) |
73 (93.6) |
117 (92.1) |
0.855
#
|
ACE-I/ARB, n (%) |
56 (67.5) |
55 (70.5) |
95 (74.8) |
0.502
#
|
Statin, n (%) |
53 (63.9) |
50 (64.9) |
80 (63.0) |
0.961
#
|
Laboratory data |
|
|
|
|
Hematocrit (%) |
39.1±5.5 |
38.2±5.7 |
38.9±5.1 |
0.517*
|
Hemoglobin (g/dL) |
12.9±1.8 |
12.7±2.0 |
12.9±1.9 |
0.755
*
|
HbA1c, (%) |
6.5±0.5b
|
8.0±0.5b
|
10.6±1.2b
|
< 0.001
¶ |
Creatinine (mg/dL) |
0.9±0.3b
|
1.0±0.3 |
1.1±0.3 |
0.010 ¶ |
C Reactive protein (mg/dL) |
8.9±7.2 |
8.3±6.5 |
9.5±8.6 |
0.801
¶
|